{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:51:42Z","timestamp":1791057102525,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,10,10]],"date-time":"2009-10-10T00:00:00Z","timestamp":1255132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00259-009-1279-6","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T10:16:44Z","timestamp":1255083404000},"page":"453-461","source":"Crossref","is-referenced-by-count":34,"title":["First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation"],"prefix":"10.1007","volume":"37","author":[{"given":"Etienne","family":"Garin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Ardisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Laffont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Boudjema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bourguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Raoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,10]]},"reference":[{"key":"1279_CR1","first-page":"473","volume-title":"Nuclear medicine in clinical diagnosis and treatment, vol. 1","author":"E Garin","year":"2004","unstructured":"Garin E, Bourguet P. Radiolipiodol of liver tumors. Use of labelled lipiodol in the treatment of hepatic tumors. In: Ell PJ, Gambhir SS, editors. Nuclear medicine in clinical diagnosis and treatment. 3rd ed, vol 1. Edinburgh: Elsevier Science; 2004. p. 473\u2013483.","edition":"3"},{"issue":"3","key":"1279_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2005.09.007","volume":"64","author":"JL Raoul","year":"2006","unstructured":"Raoul JL, Boucher E, Olivier D, Guilligomar\u2019ch A, Boudjema K, Garin E. Association of cisplatin (CDDP) and intraarterial injection of 131I-lipiodol in the treatment of hepatocellular carcinoma: results of a phase II trial. Int J Radiat Oncol Biol Phys 2006;64(3):745\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1279_CR3","first-page":"1782","volume":"35","author":"JL Raoul","year":"1994","unstructured":"Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994;35:1782\u20137.","journal-title":"J Nucl Med"},{"key":"1279_CR4","first-page":"1156","volume":"26","author":"JL Raoul","year":"1997","unstructured":"Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P, et al. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997;26:1156\u201361.","journal-title":"Hepatology"},{"key":"1279_CR5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiology.172.3.2549567","volume":"172","author":"S Houle","year":"1989","unstructured":"Houle S, Yip TCK, Shepherd FA, Rotstein LE, Sniderman KW, Theis E, et al. Hepatocellular carcinoma: a pilot trial of treatment with Y-90 microspheres. Radiology 1989;172:857\u201360.","journal-title":"Radiology"},{"key":"1279_CR6","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/1097-0142(19921101)70:9<2250::AID-CNCR2820700906>3.0.CO;2-4","volume":"70","author":"FA Shepherd","year":"1992","unstructured":"Shepherd FA, Rotstein LE, Houle S, Yip TCK, Paul K, Sniderman KW. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992;70:2250\u20134.","journal-title":"Cancer"},{"issue":"9 Pt 2","key":"1279_CR7","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S1051-0443(07)61790-4","volume":"13","author":"R Salem","year":"2002","unstructured":"Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002;13(9 Pt 2):S223\u20139.","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"1279_CR8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 2006;17(8):1251\u201378.","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"1279_CR9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000164324.79242.B2","volume":"16","author":"DM Liu","year":"2005","unstructured":"Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 2005;16(7):911\u201335.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1279_CR10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","volume":"30","author":"RJ Lewandowski","year":"2007","unstructured":"Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007;30(4):571\u201392.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1279_CR11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00006231-200306000-00009","volume":"24","author":"E Garin","year":"2003","unstructured":"Garin E, Laffont S, Rolland Y, Olivie D, Lecloirec J, Herry JY, et al. Safe radiation exposure of medical personnel using simple radioprotection means while administering 131I-lipiodol therapy for hepatocellular carcinoma. Nucl Med Commun 2003;24:671\u20138.","journal-title":"Nucl Med Commun"},{"key":"1279_CR12","first-page":"1587","volume":"42","author":"S Ho","year":"2001","unstructured":"Ho S, Lau JWY, Leung TWT. Intrahepatic 90Y-microspheres for hepatocellular carcinoma. J Nucl Med 2001;42:1587\u20139.","journal-title":"J Nucl Med"},{"issue":"5","key":"1279_CR13","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","volume":"60","author":"AS Kennedy","year":"2004","unstructured":"Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004;60(5):1552\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"1279_CR14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","volume":"16","author":"R Salem","year":"2005","unstructured":"Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005;16(12):1627\u201339.","journal-title":"J Vasc Interv Radiol"},{"key":"1279_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/cbr.2000.15.65","volume":"15","author":"JH Risse","year":"2000","unstructured":"Risse JH, Gr\u00fcnvald F, Kersjes W, Strunk H, Caselman WH, Palmedo H, et al. Intraarterial HCC therapy with I-131-Lipiodol. Cancer Biother Radiopharm 2000;15:65\u201371.","journal-title":"Cancer Biother Radiopharm"},{"issue":"4","key":"1279_CR16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359(4):378\u201390.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1279-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1279-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1279-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:01:49Z","timestamp":1558713709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1279-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,10]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1279-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,10]]}}}